info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Absorbable Heart Stent Market Share

ID: MRFR//0669-HCR | 80 Pages | Author: Kinjoll Dey| December 2024

Obtaining administrative endorsement is urgent in the clinical gadget industry, and organizations in the absorbable heart stent market are focusing on thorough clinical preliminaries to show the security and adequacy of their items. Accomplishing administrative consistence guarantees market passage as well as constructs trust among healthcare experts and patients, adding to expanded market share.
Teaching healthcare experts, especially interventional cardiologists, on the legitimate use and advantages of absorbable heart stents is a designated system. Organizations are putting resources into doctor training projects, studios, and instructive materials to build awareness and inclination among experts, affecting item reception and getting market share.
In an important market, organizations are embracing a technique of cost-viability to make absorbable heart stents more open to a more extensive patient population. Offering reasonable yet top notch arrangements guarantee far reaching reception, adding to expanded market entrance and an upper hand as far as market share.
Organizations are executing post-market observation projects to screen the drawn-out presentation and wellbeing of absorbable heart stents. This obligation to continuous item appraisal guarantees patient wellbeing as well as constructs certainty among healthcare experts, further getting market share in the advancing scene of cardiovascular mediations.
Utilizing computerized marketing systems and online stages, organizations are improving their market perceivability. This incorporates advancing absorbable heart stents through computerized channels, drawing in with patients and healthcare experts via virtual entertainment, and giving web-based assets. A solid web-based presence adds to expanded item awareness and a important situation in the absorbable heart stent market.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Forecast Period   2023-2032
Growth Rate   13.2% CAGR

Absorbable Heart Stent Market Overview


The absorbable heart stent market is anticipated to grow substantially in the years to come. The absorbable heart stent market is expected to reach USD 0.44 Billion by 2032 at 13.2% CAGR during the forecast period 2023-2032.


Stents are little inflatable tubes used to inflate the patient's arteries and prevent them from becoming blocked. These are referred to as heart stents or cardiac stents. Stents are put into the arteries of patients suffering from coronary disease as a result of plaque build-up. It is used to open constricted arteries, which helps to reduce chest discomfort and the risk of a heart attack. These stents are often used to treat coronary and peripheral arterial disorders.


The surge in the prevalence of coronary artery disease and the accompanying spike in the proportion of PCI operations is one of the major reasons projected to drive the growth and demand for absorbable cardiac stents. Also, the increase in the number of chronically ill patients and increased government initiatives for healthcare reforms are expected to drive development in the absorbable heart stent market during the forecast period.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The absorbable cardiac stent market saw a slight downfall due to the lockdown and physical distancing.


The pandemic has slightly hindered the market growth, which has affected the forecast market value significantly. However, the pandemic situation is expected to wear off in the coming years. Hence, the absorbable heart stent market will see steady growth in the forecast years.


Market Dynamics


Drivers


A few factors may drive the growth of the absorbable heart stent market share. The growing number of people suffering from chronic illnesses, such as cardiovascular disease, is likely a prominent market growth factor. In addition, the worldwide population's rising unhealthy habits, lack of physical activity, and incidence of heart ailments all contribute to the market growth.


Opportunities


The increased use of such stents by healthcare doctors, regulatory approvals, increased awareness about the benefits of absorbable heart stents, and dramatic growth in patients' needs for minimally invasive treatments are estimated to boost opportunities for the absorbable heart stent market growth throughout the forecast period. The demand for cardiac stents is also increasing because of the advancement in technology of the equipment and a rise in the number of cardiac surgeries worldwide.


Restraints


There are a few factors that may hinder the growth of the absorbable heart stent market value. The high price of absorbable cardiac stents and product failure and recalls are expected to impede the market's growth.


Challenges


Some factors that may challenge the key absorbable heart stent providers include the cost of the equipment. The decreasing prices of stents and the different challenges of stent implantation may pose a hurdle to expanding the absorbable cardiac stent market.


Cumulative Growth Analysis


The absorbable heart stent market is anticipated to grow substantially in the years to come. The absorbable cardiac stent market value is expected to grow at a CAGR of about 11.8%. The market value is anticipated to reach USD 428.4 million by the end of the year 2025. The market was evaluated at approximately USD 264.6 million in the year 2018.


Value Chain Analysis


Cardiovascular illnesses are a serious public health problem, and their incidence is steadily growing. Sedentary lifestyles, rising obesity rates, and alcohol addiction are all factors in developing cardiovascular diseases. Another important driver of the worldwide market for absorbable cardiac stents is an increase in the geriatric population. Hypertension, overweight, diabetes, cigarette use, dyslipidemia, insufficient physical activity, and a family medical history of heart disease are all major risk factors for cardiovascular disease in the older population. The increased use of stents in cardiac surgeries has led to a rise in absorbable heart stents.


Segment Overview


The absorbable heart stent market is classified into many segments such as material, application, and end-user. Listed below are the absorbable cardiac stent market segments:


By Material 



  • Metal

  • Polymer


By Application



By End-user



  • Hospitals & clinics

  • Medical research institutes & organizations

  • Cardiovascular centres

  • Others


Regional Analysis


The regional division of the absorbable heart stent market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. The business in the Americas is expected to grow at a steady rate over the forecast period due to a rising number of chronic illness patients and government initiatives for healthcare reform. Furthermore, the usage of these stents by healthcare professionals is increasing.


The choice of patients for minimally invasive therapy is propelling the absorbable cardiac stent market in this region. During the forecast period, the European market will also grow significantly. This region's market development may be because of the large patient pool and incidence of CAD and PAD.


Because of the increased development of healthcare infrastructures, the Asia-Pacific market is likely to dominate the worldwide absorbable cardiac stent market. Furthermore, the number of patients suffering from diseases, such as cardiovascular disease, is increasing. For example, the World Heart Federation estimates that cardiovascular disease accounted for 87 percent of total adult fatalities in China during 2016. The Middle East and Africa market is predicted to develop rapidly owing to a rise in the usage of surgical therapy for cardiovascular illnesses in the area.


Competitive Landscape


The absorbable heart stent industry is dominated by a few companies that play a vital role in the market growth. These absorbable cardiac stent companies are called key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting various absorbable heart stent market trends such as joint ventures, product launches, company expansions, and procurements.


Key Players


Below are the key companies that offer absorbable heart stent in the global market:



  • Boston Scientific Corporation

  • Braun Melsungen AG

  • Abbott Laboratories

  • Elixir Medical Corporation

  • Medtronic

  • Meril Life Sciences Pvt. Ltd.

  • Biotronik

  • Kyoto Medical Planning Co. Ltd.

  • REVA Medical Inc.

  • Terumo Medical Corporation


Recent Developments



  • Abbott paid USD 25 billion in January 2016 to buy St. Jude Medical, Inc. (U.S.), a maker of devices for heart problems, fibrillation, and cardiac rhythm management. Abbott was able to improve its cardiac interventional product portfolio and expand its position in the market in the cardiovascular devices industry as a result of the purchase.

  • Boston Scientific partnered with the Mayo Clinic (U.S.) in May 2016 to exchange intellectual property and accelerate the development of medical equipment. This partnership focuses on advancing medical technology in interventional cardiology, cardiac rhythm control, endoscopy, neuromodulation, urology, and pelvic care. This will assist the organization in expanding its product portfolio.


Report Overview


This report delivers all the information about the absorbable heart stent market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected absorbable heart stent market outlook by 2025.


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.